This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: DELL FOSL AVP CLF GRPN

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Addvantage Technologies (AEY) upgraded to buy at TheStreet Ratings.

First Majestic Silver (AG) downgraded to hold at TheStreet Ratings.

Avon Products (AVP - Get Report) upgraded at B. Riley Caris from neutral to buy, B. Riley Caris said. $26 price target. Turnaround may not be smooth, but is occurring.

Avon upgraded at UBS to neutral from sell, UBS said. $21 price target. Despite strong quarter, recovery will not be linear.

Armstrong World Industries (AWI) upgraded at Citigroup to buy from neutral, Citigroup said. $67 price target. Improving nonresidential construction and low expectations.

Cliffs Natural Resources (CLF - Get Report) downgraded at Citigroup to neutral from buy, Citigroup said. $36 price target. Deeper issues than perceived.

Cliffs Natural downgraded at Deutsche from buy to hold, Deutsche Bank said. $38 price target. Unexpected share issuance will cause 19% to 21% dilution.

Comcast (CMCSA) upgraded at Credit Suisse from neutral to outperform, Credit Suisse said. $48 price target. NBC Universal buyout is a positive and the company will return more cash to shareholders.

Dell (DELL - Get Report) downgraded at Bernstein from outperform to market perform, Bernstein Research said. Valuation call, based on a $15 price target.

Fossil (FOSL - Get Report) downgraded at FBR from market perform to underperform, FBR Capital Markets said. $95 price target. Earnings growth is decelerating.

Groupon (GRPN - Get Report) upgraded at Sterne Agee from neutral to buy, Sterne Agee said. $9 price target. Contrarian call, based on the company's long-term prospects.

Heinz (HNZ) downgraded at UBS to neutral from buy, UBS said. $62 price target. Progress in restoring core US momentum remains slow.

Ironwood Pharmaceutical (IRWD) upgraded at Wedbush to neutral from underperform, Wedbush said. $13 price target. LINZESS strong out of the gates.

Molina Healthcare (MOH) upgraded at BofA to buy from neutral, Bank of America Merrill Lynch said. $41 price target. Strong momentum and HCR tailwinds.

Owens Corning (OC) downgraded at Citigroup to neutral from buy, Citigroup said. $48 price target. Valuation call.

Protective Life (PL) upgraded at BofA to neutral from underperform, Bank of America Merrill Lynch said. $33 price target. M&A could yield further EPS upside.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
DELL $0.00 0.00%
AVP $9.12 1.10%
CLF $6.12 1.60%
FOSL $82.01 -2.10%
GRPN $7.01 -1.50%

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs